ETSIT-EN  ¦ Studies  ¦ Bachelor of Science in Biomedical Engineering  ¦ Presentation  ¦  Antecedents of the degree

Antecedents of the degree


For the definition of the degree of Bachelor of Biomedical Engineering from the Universidad Politécnica de Madrid in addition to the conclusions drawn from the experience and analysis of traditional market, it was considered necessary to explore what we understand will demand professional future, that indeed makes significant changes to that vision. To cut a very long this analysis we include here only a recent prospective studies that consider solid references for our application environment, for the great intrinsic value derived from the category of the signers, including the vast majority of relevant researchers in Engineering and Biomedical Technology of Spain, and have the necessary international dimension. Degree program in Biomedical Engineering, UPM is the result of the determination to the University to have a strong and stable activity in technology applications to life sciences within the BioTech Program. And take advantage of the long, intense and uninterrupted operation in Biomedical Engineering at the UPM of the past 35 years.

The Bachelor of Biomedical Engineering from the UPM is intercentre scope, involving several departments Centers UPM. This multidisciplinary should be understood as an essential element of the program and support its determination to eventually incorporate other collaborations that can be identified to achieve at any time bring together the best knowledge available at the UPM, stable and through collaborations with other institutions offer training of the highest possible quality and relevance to existing and foreseeable demand.

The program has several key features

  • A radical multidisciplinary unavoidable considering revising our traditional concept of disjoint unions multidisciplinary knowledge and skills of diversity discipline involved. Making a new attitude must technologists to manage creatively intense complexity where it is not possible to constrain the technology to their traditional contours and passive standby "specifications" of problems to solve; where it is necessary to acquire ability to think "out of the box" with the variety and novelty of anticipated professional needs; and where we must be able to adapt to the rapidly evolving disciplines involved in Biomedical Engineering, by the speed with which evolve disciplines, especially the biomedical side of very rapid progress.
  • It has significant resources available within the BioTech UPM program and especially in the laboratories of research, development and innovation both installed ETSIT, located in the Campus of International Excellence of Moncloa, and the Center for Biomedical Technology (CTB), located in the Campus of International Excellence Montegancedo. Laboratories that enable an intense, immersed practical training in real working environments in the world of biology, medicine and health. The availability of these laboratories and teachers and researchers working in them defines a framework from which it is possible to achieve the desired quality and internationality.
  • Proximity of the companies in the biomedical sector that will enable the student to benefit directly from the experiences and industrial needs that will determine content and methods of training and conducting business practices while in the program.
  • A decidedly international strategy, which manifests itself in the international nature of the supply and enhancing shared training programs with foreign universities, among them several US universities.

Currently there within the community of Madrid many companies that spend much of their resources to research and development activities (R & D) in different areas of the life sciences:

  • The ASEBIO Report 2008 ranks as the leading Madrid region with the highest number of firms investing in R & D Biomedical Engineering, 32% of Spain.
  • The OECD places Madrid as one of the five European regions leading biotechnology patent application. Companies like Biotools, Cellerix (Genetrix group), and Pharmamar (Zeltia Group), are in the list of the 50 largest Spanish applicants European and international patents in 2008.
  • The Ministry of Finance of the Community of Madrid in close collaboration with BioMadrid has launched the initiative to promote Madrid Bioscience Region (MBR) as a cluster of international excellence in which companies and research centers to cooperate openly.
  • PROMOMADRID (Foreign Office promotion CAM) is working to attract projects of Biomedical Engineering and foreign companies wishing to establish themselves in the community.